(Q38173642)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366116%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Endometriosis: pathogenesis and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366116%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366116%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Paola Viganò

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366116%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Edgardo Somigliana

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366116%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Luigi Fedele

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366116%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

2

Paola Viganò

1 reference

30 August 2017

24 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366116%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Endocrinology

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366116%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366116%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366116%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

261-275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366116%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrendo.2013.255

3 March 2020

exact match

0 references

cites work

Clinical practice. Endometriosis

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Epidemiology of endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The epidemiology of endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis: Epidemiology, and Etiological Factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis: epidemiology and aetiological factors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Recommendations for the design of epidemiologic studies of endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

What makes a good case-control study? Design issues for complex traits such as endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Pelvic endometriosis diagnosed in an entire nation over 20 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Economic burden of surgically confirmed endometriosis in Canada.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Pathogenesis and pathophysiology of endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The relation of endometriosis to menstrual characteristics, smoking, and exercise

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Dysplastic nevi, cutaneous melanoma, and gynecologic disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The familial risk of endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Pelvic endometriosis: reproductive and menstrual risk factors at different stages in Lombardy, northern Italy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Epidemiology of endometriosis among parous women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Association between endometriosis, dysplastic naevi and history of melanoma in women of reproductive age

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Epidemiologic determinants of endometriosis: a hospital-based case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

A case study comparing a meta-analysis and a pooled analysis of studies of sinonasal cancer among wood workers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Genetic factors contribute to the risk of developing endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Evaluation of risk factors associated with endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Body mass index in endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Association of endometriosis with body size and figure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis risk in relation to naevi, freckles and skin sensitivity to sun exposure: the French E3N cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

'Here comes the sun': pigmentary traits and sun habits in women with endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Adult physical activity and endometriosis risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Principles of phenomics in endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Diet and endometriosis risk: a literature review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Deep infiltrating endometriosis is associated with markedly lower body mass index: a 476 case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Body size and endometriosis: results from 20 years of follow-up within the Nurses' Health Study II prospective cohort.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

A metaanalysis on alcohol consumption and risk of endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Iron overload enhances epithelial cell proliferation in endometriotic lesions induced in a murine model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Nuclear factor-kappa B is constitutively activated in peritoneal endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Inflammatory status influences aromatase and steroid receptor expression in endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Potential involvement of iron in the pathogenesis of peritoneal endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Combination of estrogen and dioxin is involved in the pathogenesis of endometriosis by promoting chemokine secretion and invasion of endometrial stromal cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Disturbed estrogen and progesterone action in ovarian endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Iron storage is significantly increased in peritoneal macrophages of endometriosis patients and correlates with iron overload in peritoneal fluid.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The progesterone receptor coactivator Hic-5 is involved in the pathophysiology of endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Involvement of the nuclear factor-κB pathway in the pathogenesis of endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Proangiogenic Tie2(+) macrophages infiltrate human and murine endometriotic lesions and dictate their growth in a mouse model of the disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Increased activation of the PI3K/AKT pathway compromises decidualization of stromal cells from endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis, a disease of the macrophage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Genome-wide association meta-analysis identifies new endometriosis risk loci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

An Italian association study and meta-analysis with previous GWAS confirm WNT4, CDKN2BAS and FN1 as the first identified susceptibility loci for endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Role of estrogen receptor-β in endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Steroidogenic enzyme and key decidualization marker dysregulation in endometrial stromal cells from women with versus without endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Reduced expression of biomarkers associated with the implantation window in women with endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Activated glucocorticoid and eicosanoid pathways in endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Increased activation of nuclear factor-kappa B (NF-kappaB) in isolated peritoneal macrophages of patients with endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

"Re-educating" tumor-associated macrophages by targeting NF-kappaB.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Differential regulation of iron homeostasis during human macrophage polarized activation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Deep endometriosis: definition, pathogenesis, and clinical management.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The endoscopic localization of endometrial implants in the ovarian chocolate cyst.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Reconstruction of the ovary containing large endometriomas by an extraovarian endosurgical technique

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Chocolate cysts from ovarian follicles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

‘Blood On The Tracks’ from corpora lutea to endometriomas*

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Peritoneal fluid flow influences anatomical distribution of endometriotic lesions: why Sampson seems to be right

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis: what a pain it is.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Association between endometriosis stage, lesion type, patient characteristics and severity of pelvic pain symptoms: a multivariate analysis of over 1000 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study--Part 1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Quality of sex life in women with endometriosis and deep dyspareunia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis and mechanisms of pelvic pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Relationship between endometriotic foci and nerves in rectovaginal endometriotic nodules

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Hyperalgesia, nerve infiltration and nerve growth factor expression in deep adenomyotic nodules, peritoneal and ovarian endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Modulation of pain and hyperalgesia from the urinary tract by algogenic conditions of the reproductive organs in women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis is associated with central sensitization: a psychophysical controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The pains of endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Chronic pelvic pain and endometriosis: translational evidence of the relationship and implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Non-invasive diagnosis of endometriosis: the goal or own goal?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Validation study of nonsurgical diagnosis of endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Consensus on current management of endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Preoperative work-up for patients with deeply infiltrating endometriosis: transvaginal ultrasonography must definitely be the first-line imaging examination.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Transvaginal sonography for the assessment of ovarian and pelvic endometriosis: how deep is our understanding?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Surgery for deep endometriosis: a pathogenesis-oriented approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Treatment of pelvic pain associated with endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Revised American Society for Reproductive Medicine classification of endometriosis: 1996

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Role of surgery in endometriosis-associated subfertility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Laparoscopic surgery for pelvic pain associated with endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The effect of surgery for symptomatic endometriosis: the other side of the story.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Repetitive surgery for recurrent symptomatic endometriosis: what to do?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

A randomized trial of excision versus ablation for mild endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Surgical treatment of endometriosis: a prospective randomized double-blinded trial comparing excision and ablation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Coagulation versus excision of primary superficial endometriosis: a 2-year follow-up

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Excisional surgery versus ablative surgery for ovarian endometriomata

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The impact on ovarian reserve after laparoscopic ovarian cystectomy versus three-stage management in patients with endometriomas: a prospective randomized study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Laparoscopic management of endometriomas using a combined technique of excisional (cystectomy) and ablative surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Interventions for women with endometrioma prior to assisted reproductive technology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Complications, pregnancy and recurrence in a prospective series of 500 patients operated on by the shaving technique for deep rectovaginal endometriotic nodules

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Bowel dysfunction before and after surgery for endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Complications after surgery for deeply infiltrating pelvic endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Bowel resection for deep endometriosis: a systematic review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Laparoscopic management of bowel endometriosis: predictors of severe disease and recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Robotic versus standard laparoscopy for the treatment of endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Robotic treatment of colorectal endometriosis: technique, feasibility and short-term results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis: current and future medical therapies.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis: current therapies and new pharmacological developments.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Efficacy of vaginal danazol treatment in women with recurrent deeply infiltrating endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Gonadotrophin-releasing hormone analogues for pain associated with endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Medical treatment for rectovaginal endometriosis: what is the evidence?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Surgical versus medical treatment for endometriosis-associated severe deep dyspareunia: I. Effect on pain during intercourse and patient satisfaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Use of norethindrone acetate alone for postoperative suppression of endometriosis symptoms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Formation of ethinyl estradiol in women during treatment with norethindrone acetate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis and infertility: pathophysiology and management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Ovulation suppression for endometriosis for women with subfertility

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Laparoscopic surgery for subfertility associated with endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Surgery for endometriosis-associated infertility: a pragmatic approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The role of laparoscopy in intrauterine insemination: a prospective randomized reallocation study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Effect of patient selection on estimate of reproductive success after surgery for rectovaginal endometriosis: literature review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Reproductive performance in infertile women with rectovaginal endometriosis: is surgery worthwhile?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

A long-term follow-up study of women with asymptomatic endometriosis diagnosed incidentally at sterilization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Fertility in women with minimal endometriosis compared with normal women was assessed by means of a donor insemination program in unstimulated cycles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Randomized controlled trial of superovulation and insemination for infertility associated with minimal or mild endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Effect of endometriosis on in vitro fertilization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The effect of endometriosis on in vitro fertilisation outcome: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Role of laparoscopic treatment of endometriosis in patients with failed in vitro fertilization cycles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Surgical excision of endometriomas and ovarian reserve: a systematic review on serum antimüllerian hormone level modifications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Prospective assessment of the impact of endometriomas and their removal on ovarian reserve and determinants of the rate of decline in ovarian reserve.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Postsurgical ovarian failure after laparoscopic excision of bilateral endometriomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

IVF-ICSI outcome in women operated on for bilateral endometriomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Management of endometriomas in women requiring IVF: to touch or not to touch

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Clinical practice. In vitro fertilization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The ovarian endometrioma: why is it so poorly managed? Laparoscopic treatment of large ovarian endometrioma: why such a long learning curve?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Pharmacologic therapies in endometriosis: a systematic review.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

A call for more transparency of registered clinical trials on endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The effects of post-surgical administration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Return of chronic pelvic pain from endometriosis after raloxifene treatment: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The treatment with a COX-2 specific inhibitor is effective in the management of pain related to endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Pentoxifylline versus placebo in the treatment of infertility associated with minimal or mild endometriosis: a pilot randomized clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Pentoxifylline therapy after laparoscopic surgery for different stages of endometriosis: a prospective, double-blind, randomized, placebo-controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Pentoxifylline after conservative surgery for endometriosis: a randomized, controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Use of intraperitoneal interferon α-2b therapy after conservative surgery for endometriosis and postoperative medical treatment with depot gonadotropin-releasing hormone analog: a randomized clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

GnRH Analogues, Transvaginal Ultrasound-Guided Drainage and Intracystic Injection of Recombinant Interleukin-2 in the Treatment of Endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Anti-TNF-alpha treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Lack of transparency of clinical trials on endometriosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Recurrence of endometriosis and its control

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The effect of second-line surgery on reproductive performance of women with recurrent endometriosis: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

ESHRE guideline for the diagnosis and treatment of endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis and infertility: a committee opinion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Cancer risk after a hospital discharge diagnosis of endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The relationship of endometriosis and ovarian malignancy: a review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis and ovarian cancer: a review of clinical, pathologic, and molecular aspects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Endometriosis and ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The oncofetal protein IMP3: a novel biomarker and triage tool for premalignant atypical endometriotic lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The role of hepatocyte nuclear factor-1beta in the pathogenesis of clear cell carcinoma of the ovary

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The 'incessant menstruation' hypothesis: a mechanistic ovarian cancer model with implications for prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

ARID1A mutations in endometriosis-associated ovarian carcinomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Modulation of estrogenic action in clear cell carcinoma of the ovary (Review).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The dichotomy in the histogenesis of endometriosis-associated ovarian cancer: clear cell-type versus endometrioid-type adenocarcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Risk factors for synchronous primary endometrial and ovarian cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Clinicopathological characteristics of patients with synchronous primary endometrial and ovarian cancers: A review of 43 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Association between endometriosis and cancer: a comprehensive review and a critical analysis of clinical and epidemiological evidence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Bias versus causality: interpreting recent evidence of association between endometriosis and ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The future of medicine lies in truly shared decision making

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Life after a diagnosis with endometriosis - a 15 years follow-up study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

The social and psychological impact of endometriosis on women's lives: a critical narrative review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.255

Menstrual cycle characteristics and the risk of endometriosis

31 March 2020

1 reference

12 December 2020

Redox-active iron-induced oxidative stress in the pathogenesis of clear cell carcinoma of the ovary

1 reference

12 December 2020

Aromatase expression in endometriosis

1 reference

12 December 2020

Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells

1 reference

12 December 2020

Endometriosis: diagnosis and management.

1 reference

12 December 2020

Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol

1 reference

12 December 2020

Fertility considerations in laparoscopic treatment of infiltrative bowel endometriosis

1 reference

12 December 2020

The outcomes of repeat surgery for recurrent symptomatic endometriosis

1 reference

12 December 2020

Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells

1 reference

12 December 2020

Endometriosis and body fat distribution

1 reference

12 December 2020

Characteristics related to the prevalence of minimal or mild endometriosis in infertile women. Canadian Collaborative Group on Endometriosis

1 reference

12 December 2020

Actuarial analysis of private payer administrative claims data for women with endometriosis

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2013.255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24366116%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference